Bloom Science, Inc.

Bloom Science, Inc. company information, Employees & Contact Information

Bloom Science is a clinical-stage, central nervous system (CNS) company, trailblazing a path to transformative, novel therapeutics for patients with rare and complex neurological disorders. Bloom’s proprietary discovery platform, IrisRx™ enables a fundamentally different approach to developing medicines by harnessing our expanding insight into the Gut-Brain Axis to design and develop therapeutics that target novel biology with superior safety profiles. The IrisRx™ platform unlocks the potential for developing multi-functional therapeutics from the most common cell type in the human body, gut commensal microbes, while also utilizing an expanding proprietary knowledge base to advance therapeutic candidates based on synthetic biology. Bloom Science is advancing a deep pipeline of programs in Dravet syndrome; other rare epilepsies; Amyotrophic Lateral Sclerosis (ALS), a disease that causes nerve cells to die, which breaks the neural pathways, and causes extreme mobility loss over time; and neurodegenerative and cognitive disorders. At Bloom Science we balance fun with the serious business of changing lives. We have a values-driven culture that is built from the ground up. We empower our team members to treat every clinical trial like a patient’s life depends on it – because it does. Our leaders are in the trenches with you - committed to advancing science and moving mountains for a potentially transformational approach to medicine. For more information, visit https://bloomscience.com/

Company Details

Employees
19
Founded
-
Address
Roselle St, San Diego,california 92121,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Diego, California
Looking for a particular Bloom Science, Inc. employee's phone or email?

Bloom Science, Inc. Questions

News

Bloom Science Reports Positive Data from Phase 1 Trial of BL-001 Demonstrating Statistically Significant, Durable Weight Loss in Overweight Individuals - PR Newswire

Bloom Science Reports Positive Data from Phase 1 Trial of BL-001 Demonstrating Statistically Significant, Durable Weight Loss in Overweight Individuals PR Newswire

Bloom Science’s obesity therapy sustains weight loss after final dosing - Clinical Trials Arena

Bloom Science’s obesity therapy sustains weight loss after final dosing Clinical Trials Arena

The Known & the Unknown: Inside Algal Bloom Science - BG Independent News

The Known & the Unknown: Inside Algal Bloom Science BG Independent News

SA heads to world stage with its algal bloom science - InDaily

SA heads to world stage with its algal bloom science InDaily

Harnessing the gut–immune–brain axis to treat disease - Nature

Harnessing the gut–immune–brain axis to treat disease Nature

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS - PR Newswire

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial of BL-001, a Potential First-in-Class Therapeutic Being Developed for Both Dravet Syndrome and ALS PR Newswire

Bloom Science Granted Exclusive Option to License ALS Microbiome-based Gut Therapies - ALS News Today

Bloom Science Granted Exclusive Option to License ALS Microbiome-based Gut Therapies ALS News Today

Therapy based on live gut microbes fares well in healthy adults in trial - Dravet Syndrome News

Therapy based on live gut microbes fares well in healthy adults in trial Dravet Syndrome News

Bloom Science reports positive results from trial of BL-001 - Clinical Trials Arena

Bloom Science reports positive results from trial of BL-001 Clinical Trials Arena

Joel Bloom, Science Exhibit Innovator, Is Dead at 83 (Published 2008) - The New York Times

Joel Bloom, Science Exhibit Innovator, Is Dead at 83 (Published 2008) The New York Times

Bloom Science Raises USD $12 Million in Series A Financing - PR Newswire

Bloom Science Raises USD $12 Million in Series A Financing PR Newswire

Bloom Science closes enrolment in Phase l trial of BL-001 for Dravet syndrome - Clinical Trials Arena

Bloom Science closes enrolment in Phase l trial of BL-001 for Dravet syndrome Clinical Trials Arena

Top Bloom Science, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant